242 related articles for article (PubMed ID: 24513919)
1. Atrial fibrillation in a large population with Brugada electrocardiographic pattern: prevalence, management, and correlation with prognosis.
Giustetto C; Cerrato N; Gribaudo E; Scrocco C; Castagno D; Richiardi E; Giachino D; Bianchi F; Barbonaglia L; Ferraro A
Heart Rhythm; 2014 Feb; 11(2):259-65. PubMed ID: 24513919
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, clinical characteristics and management of atrial fibrillation in patients with Brugada syndrome.
Rodríguez-Mañero M; Namdar M; Sarkozy A; Casado-Arroyo R; Ricciardi D; de Asmundis C; Chierchia GB; Wauters K; Rao JY; Bayrak F; Van Malderen S; Brugada P
Am J Cardiol; 2013 Feb; 111(3):362-7. PubMed ID: 23206922
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine.
Bouzeman A; Traulle S; Messali A; Extramiana F; Denjoy I; Narayanan K; Marijon E; Hermida JS; Leenhardt A
Europace; 2014 Apr; 16(4):572-7. PubMed ID: 24068450
[TBL] [Abstract][Full Text] [Related]
4. [The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation].
De Sisti A; Leclercq JF; Fiorello P; Palamara A; Attuel P
G Ital Cardiol; 1998 Nov; 28(11):1253-60. PubMed ID: 9866803
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of isolated atrial flutter versus atrial flutter combined with atrial fibrillation.
Peyrol M; Sbragia P; Bonello L; Lévy S; Paganelli F
Arch Cardiovasc Dis; 2011 Oct; 104(10):530-5. PubMed ID: 22044706
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of factors affecting persistence of atrial fibrillation in patients with concomitant atrial flutter treated with percutaneous radiofrequency current ablation of the right atrial cavotricuspid isthmus.
Chodór P; Białkowska B; Hapeta B; Bugała K; Kłyś J; Pruszkowska-Skrzep P; Sredniawa B; Kalarus Z
Kardiol Pol; 2013; 71(3):247-52. PubMed ID: 23575779
[TBL] [Abstract][Full Text] [Related]
7. New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: prevalence and clinical significance.
Pappone C; Radinovic A; Manguso F; Vicedomini G; Sala S; Sacco FM; Ciconte G; Saviano M; Ferrari M; Sommariva E; Sacchi S; Ciaccio C; Kallergis EM; Santinelli V
Eur Heart J; 2009 Dec; 30(24):2985-92. PubMed ID: 19696190
[TBL] [Abstract][Full Text] [Related]
8. Atrial flutter or fibrillation is the most frequent and life-threatening arrhythmia in myotonic dystrophy.
Brembilla-Perrot B; Schwartz J; Huttin O; Frikha Z; Sellal JM; Sadoul N; Blangy H; Olivier A; Louis S; Kaminsky P
Pacing Clin Electrophysiol; 2014 Mar; 37(3):329-35. PubMed ID: 24117873
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
[TBL] [Abstract][Full Text] [Related]
10. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
[TBL] [Abstract][Full Text] [Related]
11. Hydroquinidine therapy in Brugada syndrome.
Hermida JS; Denjoy I; Clerc J; Extramiana F; Jarry G; Milliez P; Guicheney P; Di Fusco S; Rey JL; Cauchemez B; Leenhardt A
J Am Coll Cardiol; 2004 May; 43(10):1853-60. PubMed ID: 15145111
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation recurrence after drug-induced typical atrial flutter ablation.
Bandini A; Golia P; Pantoli D; Galvani M; Rusticali F
Ital Heart J; 2005 Jul; 6(7):584-90. PubMed ID: 16274021
[TBL] [Abstract][Full Text] [Related]
13. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
[TBL] [Abstract][Full Text] [Related]
14. The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
Andorin A; Gourraud JB; Mansourati J; Fouchard S; le Marec H; Maury P; Mabo P; Hermida JS; Deharo JC; Delasalle B; Esnault S; Sadoul N; Davy JM; Leenhardt A; Klug D; Defaye P; Babuty D; Sacher F; Probst V
Heart Rhythm; 2017 Aug; 14(8):1147-1154. PubMed ID: 28411139
[TBL] [Abstract][Full Text] [Related]
15. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation.
Wazni O; Marrouche NF; Martin DO; Gillinov AM; Saliba W; Saad E; Klein A; Bhargava M; Bash D; Schweikert R; Erciyes D; Abdul-Karim A; Brachman J; Gunther J; Pisano E; Potenza D; Fanelli R; Natale A
Circulation; 2003 Nov; 108(20):2479-83. PubMed ID: 14610012
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary vein triggers play an important role in the initiation of atrial flutter: Initial results from the prospective randomized Atrial Fibrillation Ablation in Atrial Flutter (Triple A) trial.
Schneider R; Lauschke J; Tischer T; Schneider C; Voss W; Moehlenkamp F; Glass A; Diedrich D; Bänsch D
Heart Rhythm; 2015 May; 12(5):865-71. PubMed ID: 25638698
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and Outcomes of Concurrently Diagnosed New Rapid Atrial Fibrillation or Flutter and New Reduced Ejection Fraction.
Rodriguez Y; Althouse AD; Adelstein EC; Jain SK; Mendenhall GS; Saba S; Shalaby AA; Voigt AH; Wang NC
Pacing Clin Electrophysiol; 2016 Dec; 39(12):1394-1403. PubMed ID: 27868213
[TBL] [Abstract][Full Text] [Related]
18. Can common-type atrial flutter be a sign of an arrhythmogenic substrate in paroxysmal atrial fibrillation? Clinical and ablative consequences in patients with coexistent paroxysmal atrial fibrillation/atrial flutter.
Moreira W; Timmermans C; Wellens HJ; Mizusawa Y; Philippens S; Perez D; Rodriguez LM
Circulation; 2007 Dec; 116(24):2786-92. PubMed ID: 18040030
[TBL] [Abstract][Full Text] [Related]
19. Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias.
Luria DM; Hodge DO; Monahan KH; Haroldson JM; Shen WK; Asirvatham SJ; Hammill SC; Munger TM; Glikson M; Gersh BJ; Packer DL; Friedman PA
J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1145-50. PubMed ID: 18554204
[TBL] [Abstract][Full Text] [Related]
20. Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias.
Page RL; Pritchett EL; Connolly S; Wilkinson WE;
J Cardiovasc Electrophysiol; 2008 Feb; 19(2):172-7. PubMed ID: 17916138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
